Mariusz Tomaniak, MD, PhD - who is this year's winner?
Mariusz Tomaniak, MD, PhD, is a specialist in cardiology. In addition to his position as a research and teaching assistant professor at the 1st Department of Cardiology UCC MUW, he is also an invasive cardiology operator and on-call cardiologist at the Invasive Cardiology Laboratory of the University Clinical Center MUW. In addition, he is a consulting cardiologist at the European Cardiovascular Research Institute in Rotterdam, and a cardiologist researcher at Erasmus University Medical Center. He is also a member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Committee on Research, Digital and Innovation (EAPCI Research, Digital and Innovation Committee, 2022-2024).
His clinical and research interests focus on invasive cardiology and diagnostic imaging, particularly the individualization of therapy for patients with coronary artery disease through new antiplatelet pharmacotherapy regimens and the application of modern cardiac diagnostic techniques and algorithms using optical coherence tomography (OCT), intracoronary ultrasound (IVUS), near-infrared spectroscopy (NIRS) and computer modeling techniques for fluid dynamics, among others. His achievements include the development and validation - in collaboration with bioengineers from Rotterdam and London - of a new method of coronary artery analysis (known as vessel fractional flow reserve - vFFR) that is more sensitive in diagnosing significant coronary artery lesions.
In 2021, Mariusz Tomaniak, MD, PhD, was awarded the prestigious Prime Minister's Award for Scientific Achievement and Best Habilitation Dissertation in Medical Sciences. He was recognized for his significant contribution to the ongoing discussion on the individualization of antiplatelet therapy in patients after percutaneous revascularization and the tremendous practical value of the research conducted. In the same year, he received an award from the Minister of Health for a series of publications: New Strategies for Antiplatelet Pharmacotherapy after Percutaneous Coronary Interventions in a Patient Population at High Risk of Ischemic and Hemorrhagic Complications. He is also the recipient of many other awards. In 2022, he was among the 10 winners of the Supertalents in Medicine competition, taking second place.
About the Supertalents in Medicine competition
The Supertalents in Medicine competition has been organized since 2012 by the editors of Pulse of Medicine magazine. The purpose of the plebiscite is to appreciate young medics who, with their impressive knowledge and commitment, are changing Polish health care for the better. Candidates for the award must be no older than 39 and are judged in three categories: scientific achievements; involvement in activities in the public space; and prospects for further development.
The top ten doctors and scientists honored in the 2024 Supertalents in Medicine competition.